Published in Transplant Proc on February 01, 1989
Liver transplantation (1). N Engl J Med (1989) 4.53
The incidence, timing, and management of biliary tract complications after orthotopic liver transplantation. Ann Surg (1994) 2.32
Technique and results of biliary reconstruction using side-to-side choledochocholedochostomy in 300 orthotopic liver transplants. Ann Surg (1994) 1.15
Biliary complications following orthotopic liver transplantation: a 10-year audit. HPB (Oxford) (2011) 0.99
Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology (2001) 3.26
Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group. Lancet (1994) 3.24
Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg (1991) 3.12
Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation. Lancet (1997) 3.11
Extended resections for hilar cholangiocarcinoma. Ann Surg (1999) 2.93
The role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence. Ann Surg (1989) 2.71
Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors. J Clin Oncol (1997) 2.16
Grading of tumors and tumorlike lesions of bone: evaluation by FDG PET. J Nucl Med (2000) 2.15
[Transplantation of a donor liver to 2 recipients (splitting transplantation)--a new method in the further development of segmental liver transplantation]. Langenbecks Arch Chir (1988) 2.02
Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study. Lancet (2000) 1.99
Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group. Transplantation (1997) 1.90
Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Radiology (1996) 1.86
Benign liver tumors: differential diagnosis and indications for surgery. World J Surg (1997) 1.83
Total hepatectomy and liver transplantation as two-stage procedure. Ann Surg (1993) 1.83
Monoclonal antibody therapy for resected Dukes' C colorectal cancer: seven-year outcome of a multicenter randomized trial. J Clin Oncol (1998) 1.77
Differential expression of the UGT1A locus in human liver, biliary, and gastric tissue: identification of UGT1A7 and UGT1A10 transcripts in extrahepatic tissue. Mol Pharmacol (1997) 1.61
Incidence of Pneumocystis carinii pneumonia after renal transplantation. Impact of immunosuppression. Transplantation (1996) 1.61
Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography. J Clin Oncol (1999) 1.58
Cystic enlargement of extrahepatic bile ducts. Surgery (1993) 1.53
Sensitivity in detecting osseous lesions depends on anatomic localization: planar bone scintigraphy versus 18F PET. J Nucl Med (1999) 1.53
Lymphadenectomy in gastric carcinoma. A prospective and prognostic study. Arch Surg (1992) 1.53
Radical resection and liver grafting as the two main components of surgical strategy in the treatment of proximal bile duct cancer. World J Surg (1988) 1.51
Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis. Am J Pathol (1997) 1.51
Differentiation between benign and malignant adrenal mass using contrast-enhanced ultrasound. Ultraschall Med (2011) 1.50
Liver graft-transmitted glioblastoma multiforme. A case report and experience with 13 multiorgan donors suffering from primary cerebral neoplasia. Transpl Int (1996) 1.47
Open heart operations after renal transplantation. Ann Thorac Surg (1997) 1.46
Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinomas. Hepatology (1998) 1.46
Improved survival in liver transplant recipients receiving prolonged-release tacrolimus in the European Liver Transplant Registry. Am J Transplant (2015) 1.46
Experiences with liver transplantation in Hannover. Hepatology (1984) 1.45
What constitutes long-term survival after surgery for hilar cholangiocarcinoma? Cancer (1997) 1.43
Plasma vs whole blood for therapeutic drug monitoring of patients receiving FK 506 for immunosuppression. Clin Chem (1994) 1.43
Venous complications after orthotopic liver transplantation. Clin Transplant (2000) 1.43
[Prolonged intensive care stay after abdominal surgery interventions with special reference to quality of life, occupational rehabilitation and economics]. Chirurg (1997) 1.42
[What is the role of nutrition in ulcerative colitis? A contribution to the current status of diet therapy in treatment of inflammatory bowel diseases]. Langenbecks Arch Chir (1995) 1.41
Adenine nucleotide metabolism and its relation to organ viability in human liver transplantation. Transplantation (1988) 1.39
Development of liver size and perfusion after reduced-size liver transplantation in children. Pediatr Transplant (2001) 1.39
Application of adjusted survival curves to renal transplant data. Methods Inf Med (1992) 1.39
[Building the future together]. Nuklearmedizin (2012) 1.39
[Multivariate analysis of prognostic factors after resection of ductal pancreatic carcinomas]. Langenbecks Arch Chir (1995) 1.38
Prospective randomized trial to assess the value of preemptive oral therapy for CMV infection following liver transplantation. Transplantation (2001) 1.38
Donor criteria in hepatic transplantation. Langenbecks Arch Chir (1994) 1.38
Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation. J Clin Oncol (1999) 1.38
FDG-PET for clinical use. Results of the 3rd German Interdisciplinary Consensus Conference, "Onko-PET III", 21 July and 19 September 2000. Eur J Nucl Med (2001) 1.36
Automatic volume delineation in oncological PET. Evaluation of a dedicated software tool and comparison with manual delineation in clinical data sets. Nuklearmedizin (2011) 1.36
Evaluation of neoadjuvant therapy response of osteogenic sarcoma using FDG PET. J Nucl Med (1999) 1.35
Emptying of the gastric substitute, glucagon-like peptide-1 (GLP-1), and reactive hypoglycemia after total gastrectomy. Dig Dis Sci (1991) 1.35
Auxiliary partial orthotopic liver transplantation (APOLT) for fulminant hepatic failure: first successful case report. World J Surg (1991) 1.31
2-(fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial. Cancer (2001) 1.30
Signs of hyperacute rejection of liver grafts in rhesus monkeys after donor-specific presensitization. Transplant Proc (1987) 1.30
Long-term results after surgery for acute mesenteric ischemia. Surgery (1997) 1.26
Patterns of donor-type microchimerism after heart transplantation. Lancet (1994) 1.25
Identification of high- and low-risk patients before liver transplantation: a prospective cohort study of nutritional and metabolic parameters in 150 patients. Hepatology (1997) 1.24
Auxiliary liver transplantation: regeneration of the native liver and outcome in 30 patients with fulminant hepatic failure--a multicenter European study. Hepatology (1996) 1.23
Liver transplantation. Transplant Proc (1987) 1.23
Lignocaine metabolite formation as a measure of pre-transplant liver function. Lancet (1989) 1.23
Results of portal thrombectomy and splanchnic thrombolysis for the surgical management of acute mesentericoportal thrombosis. Br J Surg (1997) 1.22
Long-term outcome of hepatitis C virus infection after liver transplantation. Hepatology (1997) 1.21
Chronic osteomyelitis: detection with FDG PET and correlation with histopathologic findings. Radiology (1998) 1.21
Real-time elastography and contrast-enhanced ultrasound for the assessment of thyroid nodules. Exp Clin Endocrinol Diabetes (2009) 1.21
A new technique of hepatic vein reconstruction in partial liver transplantation. Transpl Int (1988) 1.19
18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow. J Clin Oncol (1998) 1.19
Reperfusion injury to donor livers stored for transplantation. Liver Transpl Surg (1995) 1.19
Production of cytokines (TNF-alpha, IL-1-beta) and endothelial cell activation in human liver allograft rejection. Transplantation (1993) 1.19
Results of hepatic resection and transplantation for fibrolamellar carcinoma. Surg Gynecol Obstet (1992) 1.17
Current progress and future challenges in the biochemical diagnosis and treatment of pheochromocytomas and paragangliomas. Horm Metab Res (2008) 1.17
Long-term experience after ex situ liver surgery. Surgery (2000) 1.16
Analysis of sequential changes in major histocompatibility complex expression in human liver grafts after transplantation. Transplantation (1988) 1.16
Nutritional consequences of total gastrectomy: the relationship between mode of reconstruction, postprandial symptoms, and body composition. Surgery (1990) 1.16
Resection of synchronous liver metastases from colorectal cancer. World J Surg (1991) 1.15
Technique and results of biliary reconstruction using side-to-side choledochocholedochostomy in 300 orthotopic liver transplants. Ann Surg (1994) 1.15
Compartment-oriented microdissection of regional lymph nodes in medullary thyroid carcinoma. Surg Today (1994) 1.14
Assessment of pretransplant prognosis in patients with cirrhosis. Transplantation (1991) 1.13
Prognostic factors after resection of ampullary carcinoma: multivariate survival analysis in comparison with ductal cancer of the pancreatic head. Br J Surg (1995) 1.13
Total hepatectomy as temporary approach to acute hepatic or primary graft failure. Transplant Proc (1988) 1.13
Which is the best surgery for Budd-Chiari syndrome: venous decompression or liver transplantation? A single-center experience with 50 patients. Hepatology (1995) 1.13
Donor-type microchimerism associated with graft rejection eight years after liver transplantation. N Engl J Med (1994) 1.13
Hepatitis C virus reinfection in allografts after orthotopic liver transplantation. Hepatology (1992) 1.13
Emptying of the gastric substitute after total gastrectomy. Jejunal interposition versus Roux-y esophagojejunostomy. Ann Surg (1989) 1.12
Whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin's disease. Ann Oncol (1998) 1.11
Human hepatic preneoplasia: phenotypes and proliferation kinetics of foci and nodules of altered hepatocytes and their relationship to liver cell dysplasia. Virchows Arch (1997) 1.10
Immunoprophylaxis of hepatitis B virus reinfection in recipients of human liver allografts. Transplant Proc (1987) 1.10
Mycophenolate mofetil in combination with tacrolimus versus Neoral after liver transplantation. Transplant Proc (1999) 1.09
Liver transplantation for metastatic neuroendocrine tumors. Ann Surg (1997) 1.09
[Therapy of primary hepatocellular carcinoma]. Dtsch Med Wochenschr (1997) 1.08
Development, stability, and clinical correlations of allogeneic microchimerism after solid organ transplantation. Transplantation (1996) 1.08
Fluorodeoxyglucose positron emission tomography of soft tissue tumours: is a non-invasive determination of biological activity possible? Eur J Nucl Med (1999) 1.08
[On the article Kaireit T et al. "Smartphones now even smarter - possibility of using a "dose warner" "]. Rofo (2013) 1.08
Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging. Radiology (1997) 1.08
Long-term immunoprophylaxis of hepatitis B virus reinfection in recipients of human liver allografts. Transplant Proc (1987) 1.07
[Diagnostic imaging of hepatocellular carcinoma]. Dtsch Med Wochenschr (1997) 1.06
Dietary glycine inhibits the growth of B16 melanoma tumors in mice. Carcinogenesis (1999) 1.05